Showing results (661-670 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|January 30, 2018
A case report and a literature review of primary retroperitoneal mucinous cystadenoma: the importance of imaging in diagnosis and managementFilippo Pesapane, Sofie Van Renterghem, Francesca Patella, et al.
Future Oncology (London, England)|January 31, 2018
CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemiaChetasi Talati, Jeffrey E Lancet
Future Oncology (London, England)|August 25, 2017
County level incidence rates of chronic lymphocytic leukemia are associated with residential radon levelsS Cristina Oancea, Bradley C Rundquist, Isaac Simon, et al.
Future Oncology (London, England)|January 13, 2018
The role of nivolumab in melanomaFabio Gomes, Patricio Serra-Bellver, Paul Lorigan
Future Oncology (London, England)|January 19, 2018
Medical management of brain metastases and leptomeningeal disease in patients with breast carcinomaKelsey M Bowman, Priya Kumthekar
Future Oncology (London, England)|January 11, 2018
Ramucirumab in HER-2-positive gastroesophageal adenocarcinoma: an argument for overcoming trastuzumab resistanceMustapha Tehfe, Samer Tabchi, Maria Maddalena Laterza, et al.
Future Oncology (London, England)|January 11, 2018
Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatmentWilliam Torén, Daniel Ansari, Bodil Andersson, et al.
Future Oncology (London, England)|May 16, 2022
From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopyNing Wei, Mengyue Zhou, Siyu Lei, et al.
Future Oncology (London, England)|May 17, 2022
First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world populationAlycia Hatashima, Matthew J Arango, Joshua Reardon, et al.
Future Oncology (London, England)|May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myelomaDaanish Hoda, Robert Richards, Edward A Faber, et al.
Pageof 452